Federal contract award

75A50122P00014

THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS325413 — In-Vitro Diagnostic Substance Manufacturing
PSC6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$1.2M
Current contract value$1.2M
Potential contract value / ceiling$1.9M
Start dateJun 22, 2022
Current end dateJun 22, 2027
Potential end dateJun 22, 2027
Latest award activityAug 17, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 17, 2026P00011$143.1KTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Aug 6, 2026P00010$0THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Jul 1, 2026P00009$-47.2KTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Jun 1, 2026P00008$238.7KTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Sep 3, 2025P00007$238.7KTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Apr 30, 2025P00006$0THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Dec 30, 2024P00005$0THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Dec 2, 2024P00004$0THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Nov 21, 2024P00003$0THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
Sep 17, 2024P00002$238.7KTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS
May 5, 2023P00001$0THE PURPOSE OF THIS MODIFICATION IS TO UPDATE CLINS 1002 THROUGH 5004 TO REFLECT NEW PRICING AGREEMENT AND TO UPDATE THE CONTRACTING OFFICER AS FOLLOWS:
Jun 22, 20220$378.7KTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS.

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
65/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 65/100. Available recorded signals: 60 points.

Contract end 2027-06-22 (233 days from calculation)
+35 points
1 historical awards in this buyer and category group
+0 points
12 recorded award transactions
+10 points
Latest award action: 2026-08-17
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Amber GrayContactamber.gray@hhs.govSourceMay 23, 2022
Davis PerkinsContactdavis.perkins@hhs.govSourceMay 23, 2022
Amber GrayContactamber.gray@hhs.govSourceMay 19, 2022
Davis PerkinsContactdavis.perkins@hhs.govSourceMay 19, 2022

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.